Apoptosis in Parkinson's disease: signals for neuronal degradation.
about
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's diseaseHigh-resolution whole-genome association study of Parkinson disease.Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapyResveratrol: A Focus on Several Neurodegenerative DiseasesNuclear localization of glyceraldehyde-3-phosphate dehydrogenase is not involved in the initiation of apoptosis induced by 1-Methyl-4-phenyl-pyridium iodide (MPP+)Identification of licopyranocoumarin and glycyrurol from herbal medicines as neuroprotective compounds for Parkinson's diseaseMicroarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's diseaseThe role of biomarkers and imaging in Parkinson's disease.Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.Protective actions of ovarian hormones in the serotonin system of macaquesOvarian steroids decrease DNA fragmentation in the serotonin neurons of non-injured rhesus macaques.Neuroprotective effect of Demethoxycurcumin, a natural derivative of Curcumin on rotenone induced neurotoxicity in SH-SY 5Y Neuroblastoma cellsGT1b-induced neurotoxicity is mediated by the Akt/GSK-3/tau signaling pathway but not caspase-3 in mesencephalic dopaminergic neuronsSulfated Hetero-Polysaccharides Protect SH-SY5Y Cells from H₂O₂-Induced Apoptosis by Affecting the PI3K/Akt Signaling PathwayThe transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition.Mutant alpha-synuclein exacerbates age-related decrease of neurogenesis.Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigsMolecular imaging of cell death in an experimental model of Parkinson's disease with a novel apoptosis-targeting peptide.Role of apoptosis signal-regulating kinase 1 (ASK1) as an activator of the GAPDH-Siah1 stress-signaling cascade.In vitro neuroprotective potential of four medicinal plants against rotenone-induced toxicity in SH-SY5Y neuroblastoma cells.Intervertebral disc degeneration: the role of the mitochondrial pathway in annulus fibrosus cell apoptosis induced by overload.Ursodeoxycholic Acid Ameliorates Apoptotic Cascade in the Rotenone Model of Parkinson's Disease: Modulation of Mitochondrial Perturbations.CYLD-mediated signaling and diseases.Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectivesOxidative stress in glaucomatous neurodegeneration: mechanisms and consequences.The potential role of vascular endothelial growth factor in the central nervous system.A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP.Involvement of Mu Opioid Receptor Signaling in the Protective Effect of Opioid against 6-Hydroxydopamine-Induced SH-SY5Y Human Neuroblastoma Cells Apoptosis.Expanding insights of mitochondrial dysfunction in Parkinson's disease.Ageing and neuronal vulnerability.Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?Reduced numbers of dopamine neurons in the substantia nigra pars compacta and ventral tegmental area of rats fed an n-3 polyunsaturated fatty acid-deficient diet: a stereological studyDown-regulation of p21-activated serine/threonine kinase 1 is involved in loss of mesencephalic dopamine neurons.Death in the substantia nigra: a motor tragedy.Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration.X-ray irradiation promotes apoptosis of hippocampal neurons through up-regulation of Cdk5 and p25Proaggregant nuclear factor(s) trigger rapid formation of α-synuclein aggregates in apoptotic neurons.Effect of WR-1065 on 6-hydroxydopamine-induced catalepsy and IL-6 level in rats.eSNPO: An eQTL-based SNP Ontology and SNP functional enrichment analysis platformBone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy.
P2860
Q21131066-9B7CB078-B357-40FD-B233-84341B6651BEQ24535861-2F6D0882-DC1F-4674-9C14-AB56FB9B85EFQ24654614-CCB0941E-46C8-4FF0-A93B-FCAEE36150C0Q26800952-654BDFD3-4606-4C0C-AECF-601F637E4B9DQ28284868-B8F9FEC2-DDAF-4AC9-8D02-66978695A9E6Q28539943-69640A6C-692C-40CF-968E-03B1BAE3D8CEQ28573057-F867933A-AE6D-4CD9-8828-269431BBE452Q31041660-DAA92347-436D-4F27-8B89-FCEEB44DED3CQ33389138-8D1D7011-A593-49C5-B874-38D5F01CC316Q33435072-86C70260-ECA7-4FC9-9D75-E04E7B3C2847Q33509986-7732B6C0-DAAD-418D-B1BB-5630A10DC773Q33576734-2A843969-C284-4EB8-AF51-86572303C938Q33602001-8942F03A-5C98-4F1D-84D5-94D944BF51BAQ33612237-50A6F3EE-A6F9-4C63-A6A5-5E3B063457EAQ33748087-E4FA15FD-CDF1-445A-8A73-92C3EC225C73Q33958241-2B5BAE48-A480-4CC2-A4E0-BE64E85D89F0Q34163091-9386A158-64EB-4EEF-8338-3C537659050EQ34184725-07F8E902-F106-4035-8E56-8C86A2E91656Q34801671-53D79A4A-DEC6-467A-8E3C-27A546C0147CQ35065147-B47DCA75-5CBC-4FF8-81ED-AE2AF39F44E7Q35094633-24AA5B9B-9BAD-45CE-B590-7D7D7C86B3EBQ35515556-D2037CB7-8585-45A1-BE1D-1CAFF331A9A0Q35565726-42C92F4C-2A8F-4971-A19A-18BA86F24DE4Q35608958-F704D772-68C7-43DB-A467-8F9949A881C1Q35677091-E378665D-4B75-4EF3-960E-E1F584A64F96Q35939261-141441F1-A92A-4DB8-BA53-BAD3FF21C9DAQ36147318-A14600CE-35BD-4A5C-813A-EF31FCF93BF1Q36310081-EC065931-97A0-4EED-8D4C-4866C364E266Q36404133-93BAAA01-6598-4AF7-B4AF-E5E4A5C5F577Q36428039-6455F1B1-56C0-4C95-AC24-1C159B66C170Q36499640-29D90021-9272-4C60-81CA-EF25E68BE027Q36805018-A4BA1B9E-053F-4CB3-9DAE-ED8546688E9AQ36846653-B7B5E88E-73F4-43D3-AB70-FA5111908768Q36847262-D8E4D253-D20B-41F2-B2E8-7D2406475513Q36861432-B539745D-B49C-4AF0-8A83-232525AB1A1AQ36905920-31CD9FD4-AE54-42CA-A40B-59F5A8BF48B9Q37014379-8E989118-F6AD-423F-9DA5-15FB9892A6B7Q37043711-21C66F7D-0D34-4280-B4B8-B52E52F9001FQ37137308-CD941123-33E8-4BE8-AAAC-8827AB5C3910Q37203372-BC7C025E-439B-4481-B6B3-BF2DA13C8FED
P2860
Apoptosis in Parkinson's disease: signals for neuronal degradation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Apoptosis in Parkinson's disease: signals for neuronal degradation.
@ast
Apoptosis in Parkinson's disease: signals for neuronal degradation.
@en
type
label
Apoptosis in Parkinson's disease: signals for neuronal degradation.
@ast
Apoptosis in Parkinson's disease: signals for neuronal degradation.
@en
prefLabel
Apoptosis in Parkinson's disease: signals for neuronal degradation.
@ast
Apoptosis in Parkinson's disease: signals for neuronal degradation.
@en
P2093
P356
P1433
P1476
Apoptosis in Parkinson's disease: signals for neuronal degradation.
@en
P2093
David Brown
Nadine Tatton
Ruth Chalmers-Redman
William G Tatton
P304
S61-70; discussion S70-2
P356
10.1002/ANA.10489
P478
53 Suppl 3
P577
2003-01-01T00:00:00Z